Global Alectinib Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Alectinib Industry Forecast” looks at past sales and reviews total world Alectinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Alectinib sales for 2023 through 2029. With Alectinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alectinib industry.
This Insight Report provides a comprehensive analysis of the global Alectinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alectinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Alectinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alectinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alectinib.
The global Alectinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Alectinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Alectinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Alectinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Alectinib players cover Roche and Everest Pharmaceuticals etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Alectinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Alectinib market?
What factors are driving Alectinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alectinib market opportunities vary by end market size?
How does Alectinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Alectinib Industry Forecast” looks at past sales and reviews total world Alectinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Alectinib sales for 2023 through 2029. With Alectinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alectinib industry.
This Insight Report provides a comprehensive analysis of the global Alectinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alectinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Alectinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alectinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alectinib.
The global Alectinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Alectinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Alectinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Alectinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Alectinib players cover Roche and Everest Pharmaceuticals etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Alectinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 150mg*140 Capsules
- 150mg*28 Capsules
- 20mg*1 Capsule
- 40mg*1 Capsule
- 150mg*26 Capsules
- Unresectable NSCLC
- Advanced NSCLC
- Recurrent NSCLC
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Everest Pharmaceuticals
What is the 10-year outlook for the global Alectinib market?
What factors are driving Alectinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alectinib market opportunities vary by end market size?
How does Alectinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alectinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Alectinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Alectinib by Country/Region, 2018, 2022 & 2029
2.2 Alectinib Segment by Type
2.2.1 150mg*140 Capsules
2.2.2 150mg*28 Capsules
2.2.3 20mg*1 Capsule
2.2.4 40mg*1 Capsule
2.2.5 150mg*26 Capsules
2.3 Alectinib Sales by Type
2.3.1 Global Alectinib Sales Market Share by Type (2018-2023)
2.3.2 Global Alectinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Alectinib Sale Price by Type (2018-2023)
2.4 Alectinib Segment by Application
2.4.1 Unresectable NSCLC
2.4.2 Advanced NSCLC
2.4.3 Recurrent NSCLC
2.4.4 Other
2.5 Alectinib Sales by Application
2.5.1 Global Alectinib Sale Market Share by Application (2018-2023)
2.5.2 Global Alectinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Alectinib Sale Price by Application (2018-2023)
3 GLOBAL ALECTINIB BY COMPANY
3.1 Global Alectinib Breakdown Data by Company
3.1.1 Global Alectinib Annual Sales by Company (2018-2023)
3.1.2 Global Alectinib Sales Market Share by Company (2018-2023)
3.2 Global Alectinib Annual Revenue by Company (2018-2023)
3.2.1 Global Alectinib Revenue by Company (2018-2023)
3.2.2 Global Alectinib Revenue Market Share by Company (2018-2023)
3.3 Global Alectinib Sale Price by Company
3.4 Key Manufacturers Alectinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alectinib Product Location Distribution
3.4.2 Players Alectinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ALECTINIB BY GEOGRAPHIC REGION
4.1 World Historic Alectinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Alectinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Alectinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Alectinib Market Size by Country/Region (2018-2023)
4.2.1 Global Alectinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Alectinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Alectinib Sales Growth
4.4 APAC Alectinib Sales Growth
4.5 Europe Alectinib Sales Growth
4.6 Middle East & Africa Alectinib Sales Growth
5 AMERICAS
5.1 Americas Alectinib Sales by Country
5.1.1 Americas Alectinib Sales by Country (2018-2023)
5.1.2 Americas Alectinib Revenue by Country (2018-2023)
5.2 Americas Alectinib Sales by Type
5.3 Americas Alectinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alectinib Sales by Region
6.1.1 APAC Alectinib Sales by Region (2018-2023)
6.1.2 APAC Alectinib Revenue by Region (2018-2023)
6.2 APAC Alectinib Sales by Type
6.3 APAC Alectinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alectinib by Country
7.1.1 Europe Alectinib Sales by Country (2018-2023)
7.1.2 Europe Alectinib Revenue by Country (2018-2023)
7.2 Europe Alectinib Sales by Type
7.3 Europe Alectinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alectinib by Country
8.1.1 Middle East & Africa Alectinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Alectinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Alectinib Sales by Type
8.3 Middle East & Africa Alectinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alectinib
10.3 Manufacturing Process Analysis of Alectinib
10.4 Industry Chain Structure of Alectinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alectinib Distributors
11.3 Alectinib Customer
12 WORLD FORECAST REVIEW FOR ALECTINIB BY GEOGRAPHIC REGION
12.1 Global Alectinib Market Size Forecast by Region
12.1.1 Global Alectinib Forecast by Region (2024-2029)
12.1.2 Global Alectinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alectinib Forecast by Type
12.7 Global Alectinib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Alectinib Product Portfolios and Specifications
13.1.3 Roche Alectinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alectinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Alectinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Alectinib by Country/Region, 2018, 2022 & 2029
2.2 Alectinib Segment by Type
2.2.1 150mg*140 Capsules
2.2.2 150mg*28 Capsules
2.2.3 20mg*1 Capsule
2.2.4 40mg*1 Capsule
2.2.5 150mg*26 Capsules
2.3 Alectinib Sales by Type
2.3.1 Global Alectinib Sales Market Share by Type (2018-2023)
2.3.2 Global Alectinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Alectinib Sale Price by Type (2018-2023)
2.4 Alectinib Segment by Application
2.4.1 Unresectable NSCLC
2.4.2 Advanced NSCLC
2.4.3 Recurrent NSCLC
2.4.4 Other
2.5 Alectinib Sales by Application
2.5.1 Global Alectinib Sale Market Share by Application (2018-2023)
2.5.2 Global Alectinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Alectinib Sale Price by Application (2018-2023)
3 GLOBAL ALECTINIB BY COMPANY
3.1 Global Alectinib Breakdown Data by Company
3.1.1 Global Alectinib Annual Sales by Company (2018-2023)
3.1.2 Global Alectinib Sales Market Share by Company (2018-2023)
3.2 Global Alectinib Annual Revenue by Company (2018-2023)
3.2.1 Global Alectinib Revenue by Company (2018-2023)
3.2.2 Global Alectinib Revenue Market Share by Company (2018-2023)
3.3 Global Alectinib Sale Price by Company
3.4 Key Manufacturers Alectinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alectinib Product Location Distribution
3.4.2 Players Alectinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ALECTINIB BY GEOGRAPHIC REGION
4.1 World Historic Alectinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Alectinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Alectinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Alectinib Market Size by Country/Region (2018-2023)
4.2.1 Global Alectinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Alectinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Alectinib Sales Growth
4.4 APAC Alectinib Sales Growth
4.5 Europe Alectinib Sales Growth
4.6 Middle East & Africa Alectinib Sales Growth
5 AMERICAS
5.1 Americas Alectinib Sales by Country
5.1.1 Americas Alectinib Sales by Country (2018-2023)
5.1.2 Americas Alectinib Revenue by Country (2018-2023)
5.2 Americas Alectinib Sales by Type
5.3 Americas Alectinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alectinib Sales by Region
6.1.1 APAC Alectinib Sales by Region (2018-2023)
6.1.2 APAC Alectinib Revenue by Region (2018-2023)
6.2 APAC Alectinib Sales by Type
6.3 APAC Alectinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alectinib by Country
7.1.1 Europe Alectinib Sales by Country (2018-2023)
7.1.2 Europe Alectinib Revenue by Country (2018-2023)
7.2 Europe Alectinib Sales by Type
7.3 Europe Alectinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alectinib by Country
8.1.1 Middle East & Africa Alectinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Alectinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Alectinib Sales by Type
8.3 Middle East & Africa Alectinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alectinib
10.3 Manufacturing Process Analysis of Alectinib
10.4 Industry Chain Structure of Alectinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alectinib Distributors
11.3 Alectinib Customer
12 WORLD FORECAST REVIEW FOR ALECTINIB BY GEOGRAPHIC REGION
12.1 Global Alectinib Market Size Forecast by Region
12.1.1 Global Alectinib Forecast by Region (2024-2029)
12.1.2 Global Alectinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alectinib Forecast by Type
12.7 Global Alectinib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Alectinib Product Portfolios and Specifications
13.1.3 Roche Alectinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Alectinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Alectinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 150mg*140 Capsules
Table 4. Major Players of 150mg*28 Capsules
Table 5. Major Players of 20mg*1 Capsule
Table 6. Major Players of 40mg*1 Capsule
Table 7. Major Players of 150mg*26 Capsules
Table 8. Global Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 9. Global Alectinib Sales Market Share by Type (2018-2023)
Table 10. Global Alectinib Revenue by Type (2018-2023) & ($ million)
Table 11. Global Alectinib Revenue Market Share by Type (2018-2023)
Table 12. Global Alectinib Sale Price by Type (2018-2023) & (USD/Pcs)
Table 13. Global Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 14. Global Alectinib Sales Market Share by Application (2018-2023)
Table 15. Global Alectinib Revenue by Application (2018-2023)
Table 16. Global Alectinib Revenue Market Share by Application (2018-2023)
Table 17. Global Alectinib Sale Price by Application (2018-2023) & (USD/Pcs)
Table 18. Global Alectinib Sales by Company (2018-2023) & (K Pcs)
Table 19. Global Alectinib Sales Market Share by Company (2018-2023)
Table 20. Global Alectinib Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Alectinib Revenue Market Share by Company (2018-2023)
Table 22. Global Alectinib Sale Price by Company (2018-2023) & (USD/Pcs)
Table 23. Key Manufacturers Alectinib Producing Area Distribution and Sales Area
Table 24. Players Alectinib Products Offered
Table 25. Alectinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Alectinib Sales by Geographic Region (2018-2023) & (K Pcs)
Table 29. Global Alectinib Sales Market Share Geographic Region (2018-2023)
Table 30. Global Alectinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Alectinib Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Alectinib Sales by Country/Region (2018-2023) & (K Pcs)
Table 33. Global Alectinib Sales Market Share by Country/Region (2018-2023)
Table 34. Global Alectinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Alectinib Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Alectinib Sales by Country (2018-2023) & (K Pcs)
Table 37. Americas Alectinib Sales Market Share by Country (2018-2023)
Table 38. Americas Alectinib Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Alectinib Revenue Market Share by Country (2018-2023)
Table 40. Americas Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 41. Americas Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 42. APAC Alectinib Sales by Region (2018-2023) & (K Pcs)
Table 43. APAC Alectinib Sales Market Share by Region (2018-2023)
Table 44. APAC Alectinib Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Alectinib Revenue Market Share by Region (2018-2023)
Table 46. APAC Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 47. APAC Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 48. Europe Alectinib Sales by Country (2018-2023) & (K Pcs)
Table 49. Europe Alectinib Sales Market Share by Country (2018-2023)
Table 50. Europe Alectinib Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Alectinib Revenue Market Share by Country (2018-2023)
Table 52. Europe Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 53. Europe Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 54. Middle East & Africa Alectinib Sales by Country (2018-2023) & (K Pcs)
Table 55. Middle East & Africa Alectinib Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Alectinib Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Alectinib Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 59. Middle East & Africa Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Alectinib
Table 61. Key Market Challenges & Risks of Alectinib
Table 62. Key Industry Trends of Alectinib
Table 63. Alectinib Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Alectinib Distributors List
Table 66. Alectinib Customer List
Table 67. Global Alectinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 68. Global Alectinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Alectinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 70. Americas Alectinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Alectinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 72. APAC Alectinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Alectinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 74. Europe Alectinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Alectinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 76. Middle East & Africa Alectinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Alectinib Sales Forecast by Type (2024-2029) & (K Pcs)
Table 78. Global Alectinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Alectinib Sales Forecast by Application (2024-2029) & (K Pcs)
Table 80. Global Alectinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Roche Basic Information, Alectinib Manufacturing Base, Sales Area and Its Competitors
Table 82. Roche Alectinib Product Portfolios and Specifications
Table 83. Roche Alectinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 84. Roche Main Business
Table 85. Roche Latest Developments
Table 86. Everest Pharmaceuticals Basic Information, Alectinib Manufacturing Base, Sales Area and Its Competitors
Table 87. Everest Pharmaceuticals Alectinib Product Portfolios and Specifications
Table 88. Everest Pharmaceuticals Alectinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 89. Everest Pharmaceuticals Main Business
Table 90. Everest Pharmaceuticals Latest Developments
Table 1. Alectinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Alectinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 150mg*140 Capsules
Table 4. Major Players of 150mg*28 Capsules
Table 5. Major Players of 20mg*1 Capsule
Table 6. Major Players of 40mg*1 Capsule
Table 7. Major Players of 150mg*26 Capsules
Table 8. Global Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 9. Global Alectinib Sales Market Share by Type (2018-2023)
Table 10. Global Alectinib Revenue by Type (2018-2023) & ($ million)
Table 11. Global Alectinib Revenue Market Share by Type (2018-2023)
Table 12. Global Alectinib Sale Price by Type (2018-2023) & (USD/Pcs)
Table 13. Global Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 14. Global Alectinib Sales Market Share by Application (2018-2023)
Table 15. Global Alectinib Revenue by Application (2018-2023)
Table 16. Global Alectinib Revenue Market Share by Application (2018-2023)
Table 17. Global Alectinib Sale Price by Application (2018-2023) & (USD/Pcs)
Table 18. Global Alectinib Sales by Company (2018-2023) & (K Pcs)
Table 19. Global Alectinib Sales Market Share by Company (2018-2023)
Table 20. Global Alectinib Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Alectinib Revenue Market Share by Company (2018-2023)
Table 22. Global Alectinib Sale Price by Company (2018-2023) & (USD/Pcs)
Table 23. Key Manufacturers Alectinib Producing Area Distribution and Sales Area
Table 24. Players Alectinib Products Offered
Table 25. Alectinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Alectinib Sales by Geographic Region (2018-2023) & (K Pcs)
Table 29. Global Alectinib Sales Market Share Geographic Region (2018-2023)
Table 30. Global Alectinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Alectinib Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Alectinib Sales by Country/Region (2018-2023) & (K Pcs)
Table 33. Global Alectinib Sales Market Share by Country/Region (2018-2023)
Table 34. Global Alectinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Alectinib Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Alectinib Sales by Country (2018-2023) & (K Pcs)
Table 37. Americas Alectinib Sales Market Share by Country (2018-2023)
Table 38. Americas Alectinib Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Alectinib Revenue Market Share by Country (2018-2023)
Table 40. Americas Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 41. Americas Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 42. APAC Alectinib Sales by Region (2018-2023) & (K Pcs)
Table 43. APAC Alectinib Sales Market Share by Region (2018-2023)
Table 44. APAC Alectinib Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Alectinib Revenue Market Share by Region (2018-2023)
Table 46. APAC Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 47. APAC Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 48. Europe Alectinib Sales by Country (2018-2023) & (K Pcs)
Table 49. Europe Alectinib Sales Market Share by Country (2018-2023)
Table 50. Europe Alectinib Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Alectinib Revenue Market Share by Country (2018-2023)
Table 52. Europe Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 53. Europe Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 54. Middle East & Africa Alectinib Sales by Country (2018-2023) & (K Pcs)
Table 55. Middle East & Africa Alectinib Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Alectinib Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Alectinib Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Alectinib Sales by Type (2018-2023) & (K Pcs)
Table 59. Middle East & Africa Alectinib Sales by Application (2018-2023) & (K Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Alectinib
Table 61. Key Market Challenges & Risks of Alectinib
Table 62. Key Industry Trends of Alectinib
Table 63. Alectinib Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Alectinib Distributors List
Table 66. Alectinib Customer List
Table 67. Global Alectinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 68. Global Alectinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Alectinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 70. Americas Alectinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Alectinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 72. APAC Alectinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Alectinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 74. Europe Alectinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Alectinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 76. Middle East & Africa Alectinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Alectinib Sales Forecast by Type (2024-2029) & (K Pcs)
Table 78. Global Alectinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Alectinib Sales Forecast by Application (2024-2029) & (K Pcs)
Table 80. Global Alectinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Roche Basic Information, Alectinib Manufacturing Base, Sales Area and Its Competitors
Table 82. Roche Alectinib Product Portfolios and Specifications
Table 83. Roche Alectinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 84. Roche Main Business
Table 85. Roche Latest Developments
Table 86. Everest Pharmaceuticals Basic Information, Alectinib Manufacturing Base, Sales Area and Its Competitors
Table 87. Everest Pharmaceuticals Alectinib Product Portfolios and Specifications
Table 88. Everest Pharmaceuticals Alectinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 89. Everest Pharmaceuticals Main Business
Table 90. Everest Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Alectinib
Figure 2. Alectinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alectinib Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Alectinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Alectinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 150mg*140 Capsules
Figure 10. Product Picture of 150mg*28 Capsules
Figure 11. Product Picture of 20mg*1 Capsule
Figure 12. Product Picture of 40mg*1 Capsule
Figure 13. Product Picture of 150mg*26 Capsules
Figure 14. Global Alectinib Sales Market Share by Type in 2022
Figure 15. Global Alectinib Revenue Market Share by Type (2018-2023)
Figure 16. Alectinib Consumed in Unresectable NSCLC
Figure 17. Global Alectinib Market: Unresectable NSCLC (2018-2023) & (K Pcs)
Figure 18. Alectinib Consumed in Advanced NSCLC
Figure 19. Global Alectinib Market: Advanced NSCLC (2018-2023) & (K Pcs)
Figure 20. Alectinib Consumed in Recurrent NSCLC
Figure 21. Global Alectinib Market: Recurrent NSCLC (2018-2023) & (K Pcs)
Figure 22. Alectinib Consumed in Other
Figure 23. Global Alectinib Market: Other (2018-2023) & (K Pcs)
Figure 24. Global Alectinib Sales Market Share by Application (2022)
Figure 25. Global Alectinib Revenue Market Share by Application in 2022
Figure 26. Alectinib Sales Market by Company in 2022 (K Pcs)
Figure 27. Global Alectinib Sales Market Share by Company in 2022
Figure 28. Alectinib Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Alectinib Revenue Market Share by Company in 2022
Figure 30. Global Alectinib Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Alectinib Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Alectinib Sales 2018-2023 (K Pcs)
Figure 33. Americas Alectinib Revenue 2018-2023 ($ Millions)
Figure 34. APAC Alectinib Sales 2018-2023 (K Pcs)
Figure 35. APAC Alectinib Revenue 2018-2023 ($ Millions)
Figure 36. Europe Alectinib Sales 2018-2023 (K Pcs)
Figure 37. Europe Alectinib Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Alectinib Sales 2018-2023 (K Pcs)
Figure 39. Middle East & Africa Alectinib Revenue 2018-2023 ($ Millions)
Figure 40. Americas Alectinib Sales Market Share by Country in 2022
Figure 41. Americas Alectinib Revenue Market Share by Country in 2022
Figure 42. Americas Alectinib Sales Market Share by Type (2018-2023)
Figure 43. Americas Alectinib Sales Market Share by Application (2018-2023)
Figure 44. United States Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Alectinib Sales Market Share by Region in 2022
Figure 49. APAC Alectinib Revenue Market Share by Regions in 2022
Figure 50. APAC Alectinib Sales Market Share by Type (2018-2023)
Figure 51. APAC Alectinib Sales Market Share by Application (2018-2023)
Figure 52. China Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Alectinib Sales Market Share by Country in 2022
Figure 60. Europe Alectinib Revenue Market Share by Country in 2022
Figure 61. Europe Alectinib Sales Market Share by Type (2018-2023)
Figure 62. Europe Alectinib Sales Market Share by Application (2018-2023)
Figure 63. Germany Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Alectinib Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Alectinib Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Alectinib Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Alectinib Sales Market Share by Application (2018-2023)
Figure 72. Egypt Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Alectinib in 2022
Figure 78. Manufacturing Process Analysis of Alectinib
Figure 79. Industry Chain Structure of Alectinib
Figure 80. Channels of Distribution
Figure 81. Global Alectinib Sales Market Forecast by Region (2024-2029)
Figure 82. Global Alectinib Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Alectinib Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Alectinib Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Alectinib Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Alectinib Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Alectinib
Figure 2. Alectinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alectinib Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Alectinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Alectinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 150mg*140 Capsules
Figure 10. Product Picture of 150mg*28 Capsules
Figure 11. Product Picture of 20mg*1 Capsule
Figure 12. Product Picture of 40mg*1 Capsule
Figure 13. Product Picture of 150mg*26 Capsules
Figure 14. Global Alectinib Sales Market Share by Type in 2022
Figure 15. Global Alectinib Revenue Market Share by Type (2018-2023)
Figure 16. Alectinib Consumed in Unresectable NSCLC
Figure 17. Global Alectinib Market: Unresectable NSCLC (2018-2023) & (K Pcs)
Figure 18. Alectinib Consumed in Advanced NSCLC
Figure 19. Global Alectinib Market: Advanced NSCLC (2018-2023) & (K Pcs)
Figure 20. Alectinib Consumed in Recurrent NSCLC
Figure 21. Global Alectinib Market: Recurrent NSCLC (2018-2023) & (K Pcs)
Figure 22. Alectinib Consumed in Other
Figure 23. Global Alectinib Market: Other (2018-2023) & (K Pcs)
Figure 24. Global Alectinib Sales Market Share by Application (2022)
Figure 25. Global Alectinib Revenue Market Share by Application in 2022
Figure 26. Alectinib Sales Market by Company in 2022 (K Pcs)
Figure 27. Global Alectinib Sales Market Share by Company in 2022
Figure 28. Alectinib Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Alectinib Revenue Market Share by Company in 2022
Figure 30. Global Alectinib Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Alectinib Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Alectinib Sales 2018-2023 (K Pcs)
Figure 33. Americas Alectinib Revenue 2018-2023 ($ Millions)
Figure 34. APAC Alectinib Sales 2018-2023 (K Pcs)
Figure 35. APAC Alectinib Revenue 2018-2023 ($ Millions)
Figure 36. Europe Alectinib Sales 2018-2023 (K Pcs)
Figure 37. Europe Alectinib Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Alectinib Sales 2018-2023 (K Pcs)
Figure 39. Middle East & Africa Alectinib Revenue 2018-2023 ($ Millions)
Figure 40. Americas Alectinib Sales Market Share by Country in 2022
Figure 41. Americas Alectinib Revenue Market Share by Country in 2022
Figure 42. Americas Alectinib Sales Market Share by Type (2018-2023)
Figure 43. Americas Alectinib Sales Market Share by Application (2018-2023)
Figure 44. United States Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Alectinib Sales Market Share by Region in 2022
Figure 49. APAC Alectinib Revenue Market Share by Regions in 2022
Figure 50. APAC Alectinib Sales Market Share by Type (2018-2023)
Figure 51. APAC Alectinib Sales Market Share by Application (2018-2023)
Figure 52. China Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Alectinib Sales Market Share by Country in 2022
Figure 60. Europe Alectinib Revenue Market Share by Country in 2022
Figure 61. Europe Alectinib Sales Market Share by Type (2018-2023)
Figure 62. Europe Alectinib Sales Market Share by Application (2018-2023)
Figure 63. Germany Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Alectinib Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Alectinib Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Alectinib Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Alectinib Sales Market Share by Application (2018-2023)
Figure 72. Egypt Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Alectinib Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Alectinib in 2022
Figure 78. Manufacturing Process Analysis of Alectinib
Figure 79. Industry Chain Structure of Alectinib
Figure 80. Channels of Distribution
Figure 81. Global Alectinib Sales Market Forecast by Region (2024-2029)
Figure 82. Global Alectinib Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Alectinib Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Alectinib Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Alectinib Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Alectinib Revenue Market Share Forecast by Application (2024-2029)
